NEURIZON THERAPEUTICS LIMITEDNEURIZON THERAPEUTICS LIMITEDNEURIZON THERAPEUTICS LIMITED

NEURIZON THERAPEUTICS LIMITED

No trades
See on Supercharts

NUZ fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. It operates under the Corporate and Research, and Pharmaceutical-Epichem segments. The Corporate and Research segment includes corporate overhead expenses. The Pharmaceutical-Epichem segment provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The company was founded on December 2003 and is headquartered in Claremont, Australia.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
NUZ has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company